You are here: Home » News-CM » Companies » News
Business Standard

Granules India intimates of successful USFDA inspection of Gagillapur facility

Capital Market 

Located at Hyderabad, Telangana

announced that Company's Gagillapur facility located at Hyderabad, Telangana, has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Granules India intimates of successful USFDA inspection of Gagillapur facility

Located at Hyderabad, Telangana

Located at Hyderabad, Telangana

announced that Company's Gagillapur facility located at Hyderabad, Telangana, has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Granules India intimates of successful USFDA inspection of Gagillapur facility

Located at Hyderabad, Telangana

announced that Company's Gagillapur facility located at Hyderabad, Telangana, has successfully completed US FDA inspection without any observations. This facility manufactures Finished Dosages (FDs) and Pharmaceutical Formulation Intermediates (PFIs).

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22